(NASDAQ: SNGX) Soligenix's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.
Soligenix's earnings in 2025 is -$8,266,576.On average, 1 Wall Street analyst forecast SNGX's earnings for 2025 to be -$9,750,813, with the lowest SNGX earnings forecast at -$9,750,813, and the highest SNGX earnings forecast at -$9,750,813. On average, 1 Wall Street analyst forecast SNGX's earnings for 2026 to be -$6,374,318, with the lowest SNGX earnings forecast at -$6,374,318, and the highest SNGX earnings forecast at -$6,374,318.
In 2027, SNGX is forecast to generate -$5,522,305 in earnings, with the lowest earnings forecast at -$5,522,305 and the highest earnings forecast at -$5,522,305.